New shot at stopping lung Cancer's return after surgery
NCT ID NCT07388524
Summary
This study is testing whether giving an immunotherapy drug called atezolizumab after surgery can prevent early-stage non-small cell lung cancer from returning. It will compare patients who receive the drug for one year against those who receive standard follow-up care with observation only. The goal is to see if this treatment approach keeps patients cancer-free longer than the current standard of watchful waiting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.